Cargando…
Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury
INTRODUCTION: Granulocyte colony-stimulating factor (G-CSF) is generally used for neutropaenia. Previous experimental studies revealed that G-CSF promoted neurological recovery after spinal cord injury (SCI). Next, we moved to early phase of clinical trials. In a phase I/IIa trial, no adverse events...
Ejemplares similares
-
Randomized trial of granulocyte colony-stimulating factor for spinal cord injury
por: Koda, Masao, et al.
Publicado: (2021) -
Association of TNFAIP3 Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Japanese Population
por: Kawasaki, Aya, et al.
Publicado: (2010) -
Endoscopic Removal of a Denture Lining Material Stuck in the Duodenum
por: Eizuka, Makoto, et al.
Publicado: (2022) -
Antinuclear antibodies produced in HLA-DR transgenic humanized mice developed chronic graft-versus-host disease
por: Tsuzuki, Hiroshi, et al.
Publicado: (2021) -
Segmental motion at the peak of the ossification foci is independent risk factor except for mal-alignment and thick ossification foci for poor outcome after laminoplasty for cervical ossification of the posterior longitudinal ligament: analyses in patients with positive K-line, lordotic alignment, and lower canal occupying ratio
por: Saito, Junya, et al.
Publicado: (2020)